216 related articles for article (PubMed ID: 17147488)
21. Differential regulation of bone and body composition in male mice with combined inactivation of androgen and estrogen receptor-alpha.
Callewaert F; Venken K; Ophoff J; De Gendt K; Torcasio A; van Lenthe GH; Van Oosterwyck H; Boonen S; Bouillon R; Verhoeven G; Vanderschueren D
FASEB J; 2009 Jan; 23(1):232-40. PubMed ID: 18809737
[TBL] [Abstract][Full Text] [Related]
22. A physiological role for androgen actions in the absence of androgen receptor DNA binding activity.
Pang TP; Clarke MV; Ghasem-Zadeh A; Lee NK; Davey RA; MacLean HE
Mol Cell Endocrinol; 2012 Jan; 348(1):189-97. PubMed ID: 21872641
[TBL] [Abstract][Full Text] [Related]
23. Strain-dependent variations in the response of cancellous bone to ovariectomy in mice.
Iwaniec UT; Yuan D; Power RA; Wronski TJ
J Bone Miner Res; 2006 Jul; 21(7):1068-74. PubMed ID: 16813527
[TBL] [Abstract][Full Text] [Related]
24. Deletion of membrane-bound steel factor results in osteopenia in mice.
Lotinun S; Evans GL; Turner RT; Oursler MJ
J Bone Miner Res; 2005 Apr; 20(4):644-52. PubMed ID: 15765184
[TBL] [Abstract][Full Text] [Related]
25. Androgen receptor action in osteoblasts in male mice is dependent on their stage of maturation.
Russell PK; Clarke MV; Cheong K; Anderson PH; Morris HA; Wiren KM; Zajac JD; Davey RA
J Bone Miner Res; 2015 May; 30(5):809-23. PubMed ID: 25407961
[TBL] [Abstract][Full Text] [Related]
26. Identification of novel genetic loci for bone size and mechanosensitivity in an ENU mutant exhibiting decreased bone size.
Srivastava AK; Kapur S; Mohan S; Yu H; Kapur S; Wergedal J; Baylink DJ
J Bone Miner Res; 2005 Jun; 20(6):1041-50. PubMed ID: 15883645
[TBL] [Abstract][Full Text] [Related]
27. A floxed allele of the androgen receptor gene causes hyperandrogenization in male mice.
MacLean HE; Chiu WS; Ma C; McManus JF; Davey RA; Cameron R; Notini AJ; Zajac JD
Physiol Genomics; 2008 Mar; 33(1):133-7. PubMed ID: 18171720
[TBL] [Abstract][Full Text] [Related]
28. Age-related changes in trabecular architecture differ in female and male C57BL/6J mice.
Glatt V; Canalis E; Stadmeyer L; Bouxsein ML
J Bone Miner Res; 2007 Aug; 22(8):1197-207. PubMed ID: 17488199
[TBL] [Abstract][Full Text] [Related]
29. Vitamin D action and regulation of bone remodeling: suppression of osteoclastogenesis by the mature osteoblast.
Baldock PA; Thomas GP; Hodge JM; Baker SU; Dressel U; O'Loughlin PD; Nicholson GC; Briffa KH; Eisman JA; Gardiner EM
J Bone Miner Res; 2006 Oct; 21(10):1618-26. PubMed ID: 16995817
[TBL] [Abstract][Full Text] [Related]
30. The Effects of Androgens on Murine Cortical Bone Do Not Require AR or ERĪ± Signaling in Osteoblasts and Osteoclasts.
Ucer S; Iyer S; Bartell SM; Martin-Millan M; Han L; Kim HN; Weinstein RS; Jilka RL; O'Brien CA; Almeida M; Manolagas SC
J Bone Miner Res; 2015 Jul; 30(7):1138-49. PubMed ID: 25704845
[TBL] [Abstract][Full Text] [Related]
31. Dextran sodium sulfate-induced colitis causes rapid bone loss in mice.
Hamdani G; Gabet Y; Rachmilewitz D; Karmeli F; Bab I; Dresner-Pollak R
Bone; 2008 Nov; 43(5):945-50. PubMed ID: 18675386
[TBL] [Abstract][Full Text] [Related]
32. Transgenic mice overexpressing macrophage migration inhibitory factor (MIF) exhibit high-turnover osteoporosis.
Onodera S; Sasaki S; Ohshima S; Amizuka N; Li M; Udagawa N; Irie K; Nishihira J; Koyama Y; Shiraishi A; Tohyama H; Yasuda K
J Bone Miner Res; 2006 Jun; 21(6):876-85. PubMed ID: 16753018
[TBL] [Abstract][Full Text] [Related]
33. Endogenous glucocorticoid signalling in osteoblasts is necessary to maintain normal bone structure in mice.
Kalak R; Zhou H; Street J; Day RE; Modzelewski JR; Spies CM; Liu PY; Li G; Dunstan CR; Seibel MJ
Bone; 2009 Jul; 45(1):61-7. PubMed ID: 19358901
[TBL] [Abstract][Full Text] [Related]
34. Targeted overexpression of androgen receptor in osteoblasts: unexpected complex bone phenotype in growing animals.
Wiren KM; Zhang XW; Toombs AR; Kasparcova V; Gentile MA; Harada S; Jepsen KJ
Endocrinology; 2004 Jul; 145(7):3507-22. PubMed ID: 15131013
[TBL] [Abstract][Full Text] [Related]
35. Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats.
Sampath TK; Simic P; Sendak R; Draca N; Bowe AE; O'Brien S; Schiavi SC; McPherson JM; Vukicevic S
J Bone Miner Res; 2007 Jun; 22(6):849-59. PubMed ID: 17352644
[TBL] [Abstract][Full Text] [Related]
36. Increased trabecular bone formation in mice lacking the growth factor midkine.
Neunaber C; Catala-Lehnen P; Beil FT; Marshall RP; Kanbach V; Baranowsky A; Lehmann W; Streichert T; Ignatius A; Muramatsu T; Schinke T; Amling M
J Bone Miner Res; 2010 Aug; 25(8):1724-35. PubMed ID: 20200993
[TBL] [Abstract][Full Text] [Related]
37. Normal phenotype in conditional androgen receptor (AR) exon 3-floxed neomycin-negative male mice.
Rana K; Clarke MV; Zajac JD; Davey RA; MacLean HE
Endocr Res; 2014; 39(3):130-5. PubMed ID: 24467187
[TBL] [Abstract][Full Text] [Related]
38. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
Kassem M
APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
[TBL] [Abstract][Full Text] [Related]
39. The protein tyrosine phosphatase Rptpzeta is expressed in differentiated osteoblasts and affects bone formation in mice.
Schinke T; Gebauer M; Schilling AF; Lamprianou S; Priemel M; Mueldner C; Neunaber C; Streichert T; Ignatius A; Harroch S; Amling M
Bone; 2008 Mar; 42(3):524-34. PubMed ID: 18178537
[TBL] [Abstract][Full Text] [Related]
40. Targeted disruption of nuclear factor erythroid-derived 2-like 1 in osteoblasts reduces bone size and bone formation in mice.
Kim J; Xing W; Wergedal J; Chan JY; Mohan S
Physiol Genomics; 2010 Jan; 40(2):100-10. PubMed ID: 19887580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]